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Introduction
The structure, function and remodelling of bone as an organ is dynamically regulated by complex three-dimensional (3D) interactions among various cell types, including those of the osteoblastic, osteoclastic, endothelial and haematopoietic lineages (Parfi tt, 1994; Collin-Osdoby, 1994; Parfi tt, 2000; Pogoda et al., 2005; Matsuo and Irie, 2008; . In order to investigate the mechanisms underlying physiological and pathological cellular processes in bone, animal models are often considered not satisfactory. In fact, in addition to the high costs and large degree of systemic complexity, they often do not faithfully recapitulate the biological programs specifi c of the human species and fail to be predictive of a clinical outcome (Pearce et al., 2007) . Ex vivo cultured bone explants have been proposed for studies on bone cell biology (Meghji et al., 1997) . However, long term cultures of such specimens suffer from inadequate supply of nutrients and oxygen and typically result in necrosis of the major part of the organ. Recently, the use of bioreactor devices applying mechanical loading and medium recirculation was shown to favour cell viability and prolong culture time of bone explants (David et al., 2008; Simpson et al., 2009) . Nevertheless, these studies indicate the need of further improvements in mass transfer rates, as well as the limits of large inter-and intra-donor variability among different bone explant preparations.
The alternative co-culture of osteoblastic and osteoclastic lineage cells on two-dimensional (2D) plastic or mineralised substrates has been instrumental to a number of important advances in the fi eld. Nevertheless, the approach fails to capture the 3D spatial interactions typical of a living bone organ, and was reported to possibly lead to erroneous observations and conclusions (Hutmacher et al., 2010) . So far, only a few studies have addressed the possibility to establish a 3D co-culture model for bone cells using mineralised porous scaffolds as templates. The systems, though established for animal-origin cells, have demonstrated the feasibility to reproduce both the formation of an organised bone-like matrix , and a cell-mediated substrate degradation (Nakagawa et al., 2004; Domaschke et al., 2006; . A recent study morphologically validated the extension of previous models to human cells cultured within composite scaffolds, with the perspective to test the performance of biomaterials in vitro (Heinemann et al., 2011) . Collectively, these studies warrant the further development of 3D models of bone tissue remodelling using human-derived cells, with direct monitoring of the relevant metabolic parameters and possibly reaching a higher level of fi delity to the bone 446 www.ecmjournal.org A Papadimitropoulos et al. A 3D human bone organ model organ. In this regard, the additional presence of endothelial cells could play an important role, due to their modulatory activity on osteoblastic/osteoclastic cells (Zaidi et al., 1993; Parfi tt, 2000) and considering that bone development and remodelling is closely regulated by the vascular system (Hauge et al., 2001) . Recently, we have established a co-culture model of human osteoblast and endothelial lineage cells by seeding and culturing cells freshly isolated from the stromal vascular fraction (SVF) of adipose tissue within porous 3D ceramic scaffolds. The system, which critically relies on the use of a perfusion-based bioreactor device , was reported to generate 3D constructs that, upon implantation into nude mice, were capable to generate bone tissue and fully functional blood vessels, both of human origin (Scherberich et al., 2007) .
In the present study, we aimed at the further development of the model as a bone organotypic culture by introducing an osteoclastic cell source, namely human peripheral blood-derived monocytes (Komano et al., 2006; Sorensen et al., 2007) . The multi-cell co-culture system was assessed for the presence and functionality of its different cellular components. Moreover, non-invasive techniques were established to monitor bone-like matrix deposition and resorption in vitro and to validate the regulation of such processes by osteoclastogenic and osteotropic factors.
Materials and Methods

Cell isolation Human adipose tissue-derived stromal vascular fraction (SVF) cells
Subcutaneous adipose tissue in the form of lipoaspirates was obtained from the inner and/or outer thighs of healthy donors, after informed consent and following protocol approval by the local ethical committee. The tissue was digested in 0.075% (w/v) collagenase type II (Worthington, Lakewood, NJ, USA) for 45 min at 37 °C on an orbital shaker. The cell suspension was thereafter centrifuged at 400 g for 10 min, and the resulting pellet was washed once with phosphate-buffered saline (PBS), resuspended in α-Modifi ed Eagle's Medium (α-MEM) containing 10% of foetal bovine serum (all from Gibco, Invitrogen, Life Technologies, Carlsbad, CA, USA), and passed through a 100 μm strainer (BD Biosciences, Franklin Lakes, NJ, USA). Red blood cells were then lysed by incubation for 5 min with a buffer containing 150 mM ammonium chloride, 1.0 mM potassium bicarbonate and 0.1 mM Na-EDTA. After centrifugation and washing in PBS, the SVF cells were suspended in α-MEM supplemented with 10% FBS, 10 mM HEPES buffer, 1 mM sodium pyruvate, 100 U/ml penicillin and 100 μg/mL streptomycin (complete medium, all from Gibco, Invitrogen) and counted by using a Neubauer chamber.
Peripheral blood derived CD14+ monocytes
Mononuclear cells were isolated from human peripheral blood buffy coats from healthy donors (different from SVF cells donors) by gradient centrifugation (Ficoll, Histopaque 1077, Sigma-Aldrich, St. Louis, MO, USA). Subsequently, CD14+ monocytes were sorted using anti-CD14-coated magnetic beads (Miltenyi Biotec, Auburn, CA, USA), according to the manufacturer's instructions.
Cell cultures
Establishment of the 3D co-culture system 3D co-cultures were established using a perfusion bioreactor system, previously developed for cell seeding and cultivation into 3D scaffolds following a two-phase strategy, as shown in Fig. 1 . In the fi rst phase, 2x10 6 freshly isolated SVF resuspended in 8 mL of complete medium were perfused through 8 mm diameter, 4 mm thick disks of porous hydroxyapatite/ beta-tricalcium phosphate (HA/βTCP, 70/30 w/w, 80% porosity) scaffolds, produced by the Danish Technological Institute (DTI, Taarstrup, Denmark) using powders from Fin-Ceramica (Fin-Ceramica Faenza S.p.A, Faenza, Italy). The composition of the ceramic scaffold was selected in order to allow osteoclast resorption (Yamada et al., 1997; Detsch et al., 2008; Komlev et al., 2010) . The SVF cell suspension was perfused for 5 days at a superfi cial velocity of 400 μm/s, previously demonstrated to result in effi cient and uniform cell seeding. In the second phase, 4x10 6 freshly isolated CD14+ monocytes were introduced into each SVFpopulated scaffold using the same perfusion bioreactor system for further 4 days at a superfi cial velocity of 400 μm/s in the presence of complete medium supplemented with macrophage colony-stimulating factor (MCSF, 25 ng/ mL, R&D systems, Minneapolis, MN, USA), to promote adhesion and proliferation of monocytes. Thereafter, the culture medium was changed into complete medium supplemented with MCSF (25 ng/mL) and receptor activator for κB factor ligand (RANK-ligand, 50 ng/ mL, R&D systems) to promote osteoclast differentiation (osteoclastogenic medium) and refreshed every 4 days for an additional period of 12 days at a superfi cial velocity of 100 μm/s (the total culture time for phases 1 and 2 was 21 days). The so established co-culture will be hereafter referred to as SVF/CD14+. 3D cultures using only SVF (21 day culture) or only CD14+ (17 day culture) cells were also performed according to the protocol described above and served as controls. For each experimental group, cellfree scaffolds were similarly cultured to establish baseline levels of soluble factors in the supernatant.
In vitro functionality of the 3D co-culture system
In some experiments, the culture protocol described above was adapted in order to stimulate an osteogenic commitment of the freshly harvested SVF population and demonstrate the self-regulated osteoclastogenic capacity of the system. For this set of experiments, the duration of the fi rst culture phase was extended to 7 days using complete medium further supplemented with 5 ng/ mL fi broblast growth factor-2 (R&D Systems), 10 nM dexamethasone, and 0.1 mM L-ascorbic acid-2-phosphate (both from Sigma-Aldrich) (Scherberich et al., 2007) . During the second culture phase, medium consisted of complete medium further supplemented with 10 nM 1α,25-Dihydroxyvitamin D 3 (VitD 3 , Sigma-Aldrich). 3D cultures using complete medium or osteoclastogenic medium were also performed and served as controls. For each experimental group, cell-free scaffolds were also A Papadimitropoulos et al. A 3D human bone organ model cultured to establish baseline levels of soluble factors in the supernatant.
Supernatant analysis
Prior to each medium refresh, the media were collected, centrifuged at 400 g for 5 min and the resulting supernatant stored at -20 ºC. The samples were then thawed and assessed for C-terminus procollagen type I (CICP), crosslinked N-telopeptides of collagen type I (NTx-I, Osteomark® NTx Serum) (both from TecoMedical Group, Sissach, Switzerland), tartrate-resistant acid phosphatase isoform 5b (TRAP5b, BoneTRAP® Immunodiagnostic Systems, Boldon Business Park, UK) and phosphate levels (Biovision Inc, Mountain View, CA, USA). Each assay was performed according to the manufacturers' instructions and each value was subtracted of the corresponding one measured in cell-free scaffolds. For the quantifi cation of phosphate levels, measurements were further normalised by subtracting the levels corresponding to fresh culture medium at each medium change. Positive values corresponded to higher phosphate levels than those in the fresh culture medium in the absence of cells, indicating osteoclastic mediated resorption of the inorganic phase of the extracellular matrix (ECM) and/or of the phosphate phase of the scaffold. Conversely, negative values corresponded to lower phosphate levels than those in the fresh culture medium, indicating phosphate's embedding within the newly deposited ECM.
Scanning electron microscopy (SEM)
Formalin-fi xed constructs, harvested from the perfusion bioreactor system following 21 days of culture, were dehydrated in graded ethanol changes (30, 50, 75 , and 100% ETOH concentration), air dried and sputter coated with 20 nm of Au (Baltec Med 020, Tucson, AZ, USA). SEM observations were performed with an ESEM XL 30 apparatus (Philips, Eindhoven, The Netherlands) with 10 kV acceleration.
Cytofl uorimetric analysis
Following 3D cultures, cells were extracted from the ceramic pores by sequentially perfusing a solution of 0.3% collagenase (for 40 min) and 0.05% trypsin/0.53 mM EDTA (for 10 min) at the superfi cial velocity of 400 μm/s. Previous studies using a similar setup indicated that the protocol allows to detach more than 85% of the total cells in the system (Braccini et al., 2005) . The resulting cells were rinsed and incubated in the dark at 4 ºC for 30 min with antibodies against human CD105 (Serotec), CD90, CD34, CD45, CD31, CD14, HLA-A2 (all from BD Biosciences), STRO-1, Alkaline phosphatase (ALP) (both from R&D Systems), and analysed using a FACSCalibur fl ow cytometer (BD Biosciences). Positive expression was defi ned as the level of fl uorescence greater than 95% of the one measured using the corresponding isotype-matched control antibodies.
In vivo analyses
Constructs generated following 21 days of culture in the perfusion bioreactor system were subcutaneously implanted into dorsal pockets of recipient nude mice (CD-1 nu/nu, 1 month old; Charles River Laboratories, Wilmington, MA, USA), in accordance with institutional guidelines (Kantonales Veterinäramt Basel-Stadt", permission #1797). Eight weeks after implantation, explants were processed and analysed histologically and immunohistochemically as described below. 
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Histological staining and immunohistochemistry
After in vitro culture or in vivo implantation, constructs were fi xed in 1.5% paraformaldehyde, decalcifi ed with 7% EDTA solution (Sigma-Aldrich) and embedded in paraffi n. Sections (5 μm thick) were stained for Haematoxylin and Eosin (H&E) (J.T. Baker/Avantor, Philipsburg, NJ, USA) or for tartrate-resistant acid phosphatase (TRAP) activity using the leukocyte acid phosphatase kit (Sigma-Aldrich).
Immunohistochemical analyses were performed to assess the composition of ECM and the human origin of blood vessels or osteoclasts using antibodies against: human collagen type I (Col-I; MPBiomedicals, Solon, OH, USA), human bone sialoprotein (BSP; Enzo Life Sciences, Exeter, U.K.), human CD34 (Chemicon; Millipore, Billerica, MA, USA) and human calcitonin receptor (CTR, Acris Antibodies, Herford, Germany). The immunobinding was detected with biotinylated secondary antibodies and using the appropriate Vectastain ABC kits (Vector Labs, Burlingame, CA, USA). The red signal was developed with the Fast Red kit (Dako Cytomation, Glostrup, Denmark) and sections counterstained by Haematoxylin. Negative controls were performed for each analysis by omitting the primary antibodies. Chromogenic in situ hybridisation (CISH, Zytovision, Bremerhaven, Germany) to detect human Alu repeat sequences was performed as described in the kit. Histological and immunohistochemical sections were analysed using an Olympus BX-61 microscope (Olympus, Tokyo, Japan).
Magnetic resonance imaging (MRI)
Cultured constructs were placed in Eppendorf tubes (Sarstedt AG, Sevelen, Switzerland) fi lled with complete medium and assessed by MRI using a 3T Verio whole-body scanner (Siemens Healthcare, Munich, Germany) using a circular-polarised 12-channel receiver head coil. Multicontrast spin echo acquisitions (TR 5000 ms, 32 echoes, 16.1 ms echo spacing, 0.31x0.31 mm 2 in plane resolution, 10 mm slice thickness) were mono-exponentially fi tted (pixelwise) using MatLab R2007b (The MathWorks, Natick, MA, USA) to determine the transverse relaxation time T 2 .
Statistical analyses
All values are presented as mean ± standard deviation. Differences between experimental groups were statistically assessed using Wilcoxon's nonparametric tests. P < 0.05 was considered to indicate statistically signifi cant differences. 
Results
Establishment of a 3D multi-cell co-culture system
In order to generate a 3D co-culture model of osteoblastic, osteoclastic and endothelial lineage cells, progenitors derived from human adipose tissue and peripheral blood were sequentially loaded into porous ceramic-based scaffolds using a perfusion-based bioreactor system, as described in the Materials and Methods section and graphically illustrated in Fig. 1 . Freshly isolated cells from human adipose tissue included a highly heterogeneous set of populations, expressing mixed levels of CD14, CD31, CD34, CD73, CD90, STRO-1, alkaline phosphatase (ALP) and osteocalcin (OC), and negative for HLA-A2 (Fig. 2a) . CD14+ cells sorted from peripheral blood were predominantly positive for CD31 and HLA-A2, and negative for CD34 (Fig. 2b) . (Fig. 3a) . The latter cells were at different stages of differentiation according to (Gronthos et al., 1999) (Fig. 3b) . Control constructs seeded with SVF only contained a negligible fraction of pre/osteoclastic lineage cells, a low frequency of osteoblastic committed cells (2.6 ±2.2% STRO1 -/ALP + ) and displayed a TRAP staining pattern close to background levels (Fig. 3a,b) . As compared to the SVF/CD14+ co-culture group, SVF-based constructs yielded a lower fraction of stromal progenitor (15.6 ±2.0% vs. 26 ±2.8%) and CD105+, mesenchymal lineage cells (9.8 ±2.5% vs. 24.5 ±4.9%), while exhibited a higher percent of endothelial lineage cells (10.0 ±1.4% vs. 2.0 ±0.3%). As expected, the experimental group established using only CD14+ cells did not include CD34 + / CD31 + endothelial lineage cells and led to a loss of CD14 + / CD31 + pre/osteoclastic lineage cells during 3D culture (Fig. 2c) . Thus, only the SVF/CD14+ experimental group allowed to establish a 3D co-culture system including osteoblastic, osteoclastic and endothelial lineage cells.
Extracellular matrix (ECM) characterisation in the 3D co-culture model
We next assessed the ECM developed in the 3D engineered tissue model. Scanning electron microscopy (SEM) qualitatively but reproducibly displayed larger amounts of ECM in the pores of scaffolds seeded with SVF only, as compared to SVF/CD14+ (Fig. 4a, SEM) . No traces of ECM were found in samples established using only CD14+ cells, which were comparable to the cell-free scaffold group (data not shown). Quantitative measurements by MRI were consistent with SEM fi ndings. Specifi cally, the relaxation times T 2 for SVF/CD14+ samples were similar to those of CD14+ and cell-free samples and higher (i.e., indicating higher water content and lower ECM density) than those of SVF constructs (Fig. 4b) . Histological assessment of the in vitro cultured SVF/CD14+ constructs displayed the presence of TRAP+ osteoclastic cells (Fig. 4a, TRAP) surrounding scattered clusters of ECM intensely stained for Col-I and BSP (Fig. 4a, Col-I & BSP) . In contrast, in SVF constructs, no TRAP+ cells were detected within the abundant ECM positively stained both for Col-I and BSP. The data collectively suggest that the apparent reduction of ECM in the SVF/CD14+ group as compared to the SVF group could be due to the resorption activity by osteoclastic cells. 
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Assessment of ECM turnover using non-invasive tools
In order to non-invasively monitor the process of ECM deposition and resorption over culture time, typical markers of bone remodelling were assessed in the supernatant. Increasing levels of procollagen-I (CICP) were measured in both SVF/CD14+ and SVF conditions (up to 30% higher in the SVF/CD14+ co-culture group), indicating active and sustained deposition of ECM by mesenchymal/osteoblastic cells (Fig. 5a ). Values below the sensitivity of this assay were found for the CD14+ constructs (data not shown). The levels of osteoclast specifi c isoenzyme TRAP5b were signifi cantly higher (up to 4-fold) in the SVF/CD14+ and CD14+ conditions as compared to the SVF only culture group already from the 2 nd medium change, i.e. 4 d after the fresh CD14+ monocytes were introduced into the culture (Fig. 5b) . The levels of NTX-I, indicating osteoclastdriven degradation product of Col-I, were consistently elevated only for SVF/CD14+ samples, whereas the SVF and CD14+ experimental groups displayed signifi cantly lower or undetectable values, respectively (Fig. 5c) . Furthermore, positive phosphate values, indicating a net ECM resorption, were found only for SVF/CD14+ samples (Fig. 5d) . Phosphate levels were not detected in CD14+ samples and were negative for SVF samples, indicative of a net accumulation of ECM. These data indicate that processes of ECM deposition and resorption are actively ongoing only in the SVF/CD14+ group, likely due to the presence of both osteoblastic and osteoclastic cells.
In vivo performance of the generated 3D constructs
In order to demonstrate the full functionality of the different cell populations within the 3D co-culture model, engineered constructs were ectopically implanted in nude mice. After 8 weeks in vivo, explants from both SVF/CD14+ and SVF groups contained a high density of cells of human origin (Fig. 6a) , embedded within an ECM including scattered ossicles (Fig. 6b) and structures positively stained for human-specifi c BSP (Fig. 6c ). Blood vessels of human origin, as assessed by positive staining for human CD34, and functionally connected with the host vasculature, as indicated by the presence of erythrocytes, were also found in both conditions (Fig. 5d ). TRAP+ and human specifi c CTR+ multinucleated osteoclasts (Fig. 6e,f) were found only in constructs derived from the SVF/CD14+ co-culture. None of the above described cell types and tissue structures could be observed in the implanted cell-free scaffolds (data not shown). The generally limited amount of bone formation may be related to the culture conditions used, which -in order to promote osteoclast development -may have promoted a predominantly 'catabolic' environment.
In vitro functionality of the 3D co-culture model
In order to demonstrate a functional coupling of the different cell populations in the SVF/CD14+ 3D co-culture model, we investigated whether the presence of a well-known osteotropic agent acting on osteoblastic cells (Kitazawa et al., 2003) , namely VitD 3 , could indirectly support the formation and activity of osteoclasts. Independently of the culture medium used, the production of procollagen-I (CICP) increased over time, indicating active ECM synthesis (Fig. 7a) . Levels of the isoenzyme TRAP5b increased with culture time, indicating an increase in the number of osteoclastic cells, with no substantial differences among the experimental groups (Fig. 7b) . Instead, the osteoclastic activity of ECM resorption, assessed by positive phosphate levels in the supernatant, could be demonstrated only in the presence of osteoclastogenic (Fig. 7c) . Constructs treated with VitD 3 displayed initially negative phosphate values, indicative of ECM synthesis, followed by intermittently positive values, indicating a discontinuous ECM resorption process. In line with these results, TRAP+ cells were found in all conditions, whereas abundant ECM fi lling the scaffold pores was visible by SEM only in control samples, cultured in medium without osteoclastogenic factors or VitD 3 (Fig.  8) . In order to defi ne the fate of PB-derived monocytes when co-cultured with SVF cells, cytofl uorimetry was performed based on HLA-A2 mismatched donors. All conditions exhibited PB-derived cells (HLA-A2 + ) expressing low frequencies of the mesenchymal marker CD90 (up to 6.9%), a fraction of which appeared to co-express the panhematopoietic marker CD45 (up to 2%) ( Table 1 ). The data suggest a possible mesenchymal conversion of monocytic cells (Kuwana et al., 2003; Kuwana et al., 2006; Yeh et al., 2006) and more generally indicate the potential to track the origin of the cells developed in the co-culture system.
Discussion
In the present study, we established a 3D osteoblasticosteoclastic-endothelial cell co-culture model, using progenitor cells of human origin derived from easily available sources and a perfusion-based bioreactor device. The developed non-invasive monitoring techniques could quantitatively capture the cell-mediated processes of bone-like matrix deposition and resorption, and validated the cell-based, functional regulation of the system by osteoclastogenic or osteotropic factors.
In order to maintain osteoclastic cells in culture, with a typically short life span, until a bone-like matrix was deposited in the scaffold pores, our model was developed as a two-phase culture system. The 3D ceramic materials were thus loaded fi rst with freshly harvested SVF cells derived from adipose tissue, initially populating the accessible surface and producing ECM containing BSP and type I collagen. The preformed cell-scaffold constructs were then seeded with peripheral blood derived CD14+ osteoclastic precursor cells. The use of a bioreactor device, directly perfusing the cell suspensions through the construct pores, was instrumental to reproducibly achieve a sequential seeding of the different cell types, likely facilitating heterotypic cell interactions throughout the available spaces. Moreover, the 3D perfusion-based culture regime allowed to expand the cells harvested from the native tissues directly in the scaffolds, bypassing the typical artifactual culture phase in 2D plastic dishes, which is known to affect cell fate (Banfi et al., 2000) and was previously shown to rapidly deplete the endothelial component from human SVF cells (Scherberich et al., 2007) . One distinct feature of the developed model was thus the long-term presence in culture of endothelial cells, which are known to modulate the osteoblastic and osteoclastic activity, as well as to regulate the transition from bone matrix resorption to formation (Collin-Osdoby, 1994; Parfi tt, 2000) .
The main challenge of a 3D culture system is typically related to the inherent diffi culty of inspecting the relevant cell processes. In order to address this critical issue, noninvasive techniques were introduced for the qualitative and quantitative monitoring of ECM deposition and resorption.
In particular, a set of biochemical markers measured by off-line sampling of the culture medium was established to refl ect respectively the deposition of type I collagen, the presence of TRAP5b-secreting osteoclasts and the resorption of mineralised matrix. In addition, measurement of T 2 by magnetic resonance imaging (MRI) was shown to correspond to the SEM-detected amounts of extracellular matrix. The use of MRI could be further developed to quantify the amount of specifi c matrix molecules, for instance by combining it with collagen-specifi c peptides as contrast agents (Caravan et al., 2007) . The use of the different assays established that the active osteoclastic resorption in this model was dependent on the presence of SVF and their ECM deposition. In fact, collagen degradation products and phosphate levels in the medium were found increased only when monocytic cells were introduced in a SVF pre-seeded construct, where type I collagen was extensively produced. The active resorption process reproduced under these conditions was mirrored by the abundant loss of the SVF-produced ECM, as assessed by SEM. To the best of our knowledge, the developed 3D co-culture system is thus the fi rst in vitro model that coupled osteoclastic matrix resorption to active matrix deposition by osteoblastic cells.
In the initial confi guration, the 3D co-culture model was established by using exogenous growth and differentiating factors known to act directly on osteoclastic precursors (Lacey et al., 1998) , and which were permissive in our experimental setup to the induction/maintenance of osteoblastic and endothelial cells. The co-culture of SVF with CD14+ cells resulted in the presence of different osteoblastic cell populations, with an increased percentage of both the more immature (STRO1 + , ALP -) and the more As a next step, we aimed at demonstrating the in vitro self-regulatory capacity of the developed model, using the paradigm of VitD 3 -controlled bone resorption (Boyle et al., 2003) . In fact, it is known that VitD 3 typically induces differentiation of monocyte-macrophages into osteoclasts indirectly, by increasing the RANKL expression by stromal/osteoblastic cells (Takahashi et al., 1988; Yasuda et al., 1998; Kitazawa et al., 2003) . In our system, VitD 3 increased collagen production, supported osteoclast formation and triggered osteoclast mediated ECM resorption. Interestingly, analysis of the phosphate values, refl ecting the net effect between ECM deposition and resorption, indicated an increased resorption activity in the presence of VitD 3 , but only at alternate time points. These results may refl ect the dynamic nature of ECM turnover in the presence of a factor having both anabolic and catabolic actions on bone (Kitazawa et al., 2003) . Investigation of the possible regulation of the transition between these two states as a function of frequency and dose of VitD 3 supplementation (Miao and Scutt, 2002) was beyond the scope of the present study.
The developed 3D osteoblastic-osteoclastic-endothelial cell co-culture system and the associated analytical tools were able to capture in vitro some aspects of the functional coupling of bone-like matrix deposition and resorption and could thus be used in different contexts. The model may fi nd application in the test of drugs regulating bone homeostasis (Pampaloni et al., 2009) or in the study of biocompatibility/remodelling capacity of bone substitute materials (Kirkpatrick et al., 2007) , thus potentially decreasing the use of laboratory animals (Pampaloni et al., 2007) . The use of cells of human origin would in this regard support a possibly superior direct relevance in human physiology and pathology. The additional introduction of mechanical loading in the multi-cell model would support investigations of which specifi c cell population(s) are required in bone as an "organ" to couple biochemical and mechanical signals. By mimicking a bone organ microenvironment, the system could also be used as an engineered 3D niche to study bone-tumour cell interactions, as well as the process of cancer cell metastasis into bone during its turnover (Yin et al., 2005; Hutmacher et al., 2010) . Moreover, by presenting both osteoblastic and vascular elements, the 3D environment could be used as an advanced in vitro model to investigate the signals involved in the control of haematopoietic stem cell function (Di Maggio et al., 2011) . Last but not least, the developed methods could be exploited toward the engineering of multi-functional bone substitute implants. The intrinsic osteogenic, vasculogenic and remodelling capacity would need to be regulated to reach highly effi cient engraftment and performance, whereas the bioreactor-based processes would represent the basis for standardised and costeffective manufacturing (Martin et al., 2010) .
Conclusion
The establishment of a functional in vitro system of osteoblastic, osteoclastic and endothelial lineage cells, along with the associated non-invasive assessments, may fi nd application in a variety of different contexts. These are related to supporting fundamental science of bone biology and translation of the developed knowledge towards bone regeneration
